HLB PANAGENE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,275 KRW | -2.84% |
|
-5.21% | +3.51% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
HLB PanaGene Co Ltd, formerly Panagene Inc, is a Korea-based company mainly engaged in the development of genetic diagnostic products. The Company operates its business through three segments. The Diagnostics Business segment mainly involves in manufacturing and sales of molecular diagnostic reagents, analysis services, and consumables. The Materials Business segment mainly engages in the manufacturing and sales of custom pentose nucleic acid (PNA) oligomers. The Nucleic Acid Extraction segment mainly engages in the manufacturing and sales of nucleic acid extraction equipment and extraction reagents.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +3.51% | 127M | |
| -20.45% | 10.82B | |
| +43.17% | 3.25B | |
| -35.86% | 2.11B | |
| -17.21% | 2.08B | |
| -29.81% | 1.48B | |
| +17.56% | 1.02B | |
| -4.37% | 733M | |
| -37.00% | 391M | |
| -46.94% | 383M |
- Stock Market
- Equities
- A046210 Stock
- News HLB PANAGENE Co., LTD.
- Panagene to Raise 30 Billion Won From Shares Issuance; Shares Jump 30%
